鬼箭羽通过调节EGFR酪氨酸激酶抑制剂耐药信号通路延缓糖尿病肾病的进展

目的 结合GEO数据库利用网络药理学、分子对接技术及动物实验探究鬼箭羽治疗糖尿病肾病(DKD)的潜在作用机制.方法 通过TCMSP、PubChem及Swiss Target Prediction数据库获取鬼箭羽的活性成分和作用靶点.利用GEO数据库找出与DKD相关基因芯片,使用R语言分析筛选出差异表达基因,结合GeneCards、DisGeNet、OMIM以及TTD疾病数据库整合获取DKD的治疗靶点.利用Venny2.1.0平台将药物与DKD相关的靶基因取交,利用STRING平台构建蛋白-蛋白互作网络图,并利用Cytoscape3.8.2软件进行核心靶点的拓扑属性分析以及"药物-成分...

Full description

Saved in:
Bibliographic Details
Published in南方医科大学学报 Vol. 44; no. 7; pp. 1243 - 1255
Main Authors 王瑾瑾, 崔文飞, 窦雪伟, 尹冰磊, 牛钰琪, 牛羚, 闫国立
Format Journal Article
LanguageChinese
Published 河南中医药大学医学院,河南 郑州 450046 2024
Subjects
Online AccessGet full text
ISSN1673-4254
DOI10.12122/j.issn.1673-4254.2024.07.04

Cover

Abstract 目的 结合GEO数据库利用网络药理学、分子对接技术及动物实验探究鬼箭羽治疗糖尿病肾病(DKD)的潜在作用机制.方法 通过TCMSP、PubChem及Swiss Target Prediction数据库获取鬼箭羽的活性成分和作用靶点.利用GEO数据库找出与DKD相关基因芯片,使用R语言分析筛选出差异表达基因,结合GeneCards、DisGeNet、OMIM以及TTD疾病数据库整合获取DKD的治疗靶点.利用Venny2.1.0平台将药物与DKD相关的靶基因取交,利用STRING平台构建蛋白-蛋白互作网络图,并利用Cytoscape3.8.2软件进行核心靶点的拓扑属性分析以及"药物-成分-靶点-疾病"网络图构建;利用David平台进行KEGG与GO分析.利用Autodock vina V1.2.0软件对核心靶点及主要药效成分进行分子对接,并通过db小鼠动物实验进一步加以验证.结果 符合条件的基因芯片为GSE96804、GSE30528和GSE30529,共包含60例患病和45例正常样本数据,R语言分析得到111个差异基因.网络药理学分析显示鬼箭羽相关靶基因共226种,DKD相关靶基因共4252种,二者取交得到鬼箭羽治疗DKD的潜在靶基因共161种;PPI网络图中筛选出关键核心靶基因为SRC、EGFR、AKT1等,"药物-成分-靶点-疾病"网络图得到鬼箭羽的主要核心活性成分为槲皮素、山奈酚、香叶木素、柚皮素.GO和KEGG富集分析显示,鬼箭羽治疗DKD的生物过程与外源刺激的反应、蛋白质磷酸化等有关,可能主要通过调节EGFR酪氨酸激酶抑制剂耐药通路发挥作用.分子对接结果显示鬼箭羽的主要核心活性成分与关键核心靶点具有良好的结合活性.体内动物实验结果证明鬼箭羽能够改善肾脏组织的病理学变化,且显著抑制了SRC、EGFR、AKT1的表达(P<0.05),延缓DKD的进一步恶化.结论 鬼箭羽可能是通过槲皮素、山奈酚、香叶木素、柚皮素等多种活性成分调控SRC、EGFR、AKT1等基因表达,从而影响EGFR酪氨酸激酶抑制剂耐药信号通路治疗DKD.
AbstractList 目的 结合GEO数据库利用网络药理学、分子对接技术及动物实验探究鬼箭羽治疗糖尿病肾病(DKD)的潜在作用机制.方法 通过TCMSP、PubChem及Swiss Target Prediction数据库获取鬼箭羽的活性成分和作用靶点.利用GEO数据库找出与DKD相关基因芯片,使用R语言分析筛选出差异表达基因,结合GeneCards、DisGeNet、OMIM以及TTD疾病数据库整合获取DKD的治疗靶点.利用Venny2.1.0平台将药物与DKD相关的靶基因取交,利用STRING平台构建蛋白-蛋白互作网络图,并利用Cytoscape3.8.2软件进行核心靶点的拓扑属性分析以及"药物-成分-靶点-疾病"网络图构建;利用David平台进行KEGG与GO分析.利用Autodock vina V1.2.0软件对核心靶点及主要药效成分进行分子对接,并通过db小鼠动物实验进一步加以验证.结果 符合条件的基因芯片为GSE96804、GSE30528和GSE30529,共包含60例患病和45例正常样本数据,R语言分析得到111个差异基因.网络药理学分析显示鬼箭羽相关靶基因共226种,DKD相关靶基因共4252种,二者取交得到鬼箭羽治疗DKD的潜在靶基因共161种;PPI网络图中筛选出关键核心靶基因为SRC、EGFR、AKT1等,"药物-成分-靶点-疾病"网络图得到鬼箭羽的主要核心活性成分为槲皮素、山奈酚、香叶木素、柚皮素.GO和KEGG富集分析显示,鬼箭羽治疗DKD的生物过程与外源刺激的反应、蛋白质磷酸化等有关,可能主要通过调节EGFR酪氨酸激酶抑制剂耐药通路发挥作用.分子对接结果显示鬼箭羽的主要核心活性成分与关键核心靶点具有良好的结合活性.体内动物实验结果证明鬼箭羽能够改善肾脏组织的病理学变化,且显著抑制了SRC、EGFR、AKT1的表达(P<0.05),延缓DKD的进一步恶化.结论 鬼箭羽可能是通过槲皮素、山奈酚、香叶木素、柚皮素等多种活性成分调控SRC、EGFR、AKT1等基因表达,从而影响EGFR酪氨酸激酶抑制剂耐药信号通路治疗DKD.
Abstract_FL Objective To explore the therapeutic mechanism of Euonymus alatus for diabetic kidney disease(DKD).Methods TCMSP,PubChem and Swiss Target Prediction databases were used to obtain the active ingredients in Euonymus alatus and their targets.GEO database and R language were used to analyze the differentially expressed genes in DKD.The therapeutic targets of DKD were obtained using GeneCards,DisGeNet,OMIM and TTD databases.The protein-protein interaction network and the"drug-component-target-disease"network were constructed for analyzing the topological properties of the core targets,which were functionally annotated using GO and KEGG pathway enrichment analyses.Molecular docking was performed for the core targets and the main pharmacologically active components,and the results were verified in db/db mice.Results Analysis of GSE96804,GSE30528 and GSE30529 datasets(including 60 DKD patients and 45 normal samples)identified 111 differentially expressed genes in DKD.Network pharmacology analysis obtained 161 intersecting genes between the target genes of Euonymus alatus and DKD,including the key core target genes SRC,EGFR,and AKT1.The core active ingredients of Euonymus alatus were quercetin,kaempferol,diosmetin,and naringenin,which were associated with responses to xenobiotic stimulionus and protein phosphorylation and regulated EGFR tyrosine kinase inhibitor resistance pathways.Molecular docking suggested good binding activities of the core active components of Euonymus alatus with the core targets.In db/db mouse models of DKD,treatment with Euonymus alatus obviously ameliorated kidney pathologies,significantly inhibited renal expressions of SRC,EGFR and AKT1,and delayed the progression of DKD.Conclusion Euonymus alatus contains multiple active ingredients such as quercetin,kakaferol,diosmetin,naringenin,which regulate the expressions of SRC,EGFR,and AKT1 to affect the EGFR tyrosine kinase inhibitor resistance signaling pathway to delay the progression of DKD.
Author 崔文飞
牛羚
闫国立
窦雪伟
尹冰磊
牛钰琪
王瑾瑾
AuthorAffiliation 河南中医药大学医学院,河南 郑州 450046
AuthorAffiliation_xml – name: 河南中医药大学医学院,河南 郑州 450046
Author_FL NIU Yuqi
YAN Guoli
CUI Wenfei
YIN Binglei
WANG Jinjin
NIU Ling
DOU Xuewei
Author_FL_xml – sequence: 1
  fullname: WANG Jinjin
– sequence: 2
  fullname: CUI Wenfei
– sequence: 3
  fullname: DOU Xuewei
– sequence: 4
  fullname: YIN Binglei
– sequence: 5
  fullname: NIU Yuqi
– sequence: 6
  fullname: NIU Ling
– sequence: 7
  fullname: YAN Guoli
Author_xml – sequence: 1
  fullname: 王瑾瑾
– sequence: 2
  fullname: 崔文飞
– sequence: 3
  fullname: 窦雪伟
– sequence: 4
  fullname: 尹冰磊
– sequence: 5
  fullname: 牛钰琪
– sequence: 6
  fullname: 牛羚
– sequence: 7
  fullname: 闫国立
BookMark eNo9UEFKw0AA3EMFa-0vvHhI3Gx2N8lRSluFgiB6LpvsrrRICgaxvZVqUAuiIirUkzcRtRWhFazNZ0yz-YUVxcsMDMwMMwsg4zd8AcCSAXUDGQit1PVaEPi6QS1Tw4hgHUGEdWjpEGdA9l-eB_kgqLmQGKYFCYVZwNKncfLynEw-03ZPRcdqcKi6nWK5tJmGj9PBQxq-T6N2Gg6n3cv4ZBifdlT7Qp31v6L7-Hz04xn1449hMr5K3m7iQZTchqozmWHSO1LRXfx6vQjmJNsNRP6Pc2C7VNwqrGmVjfJ6YbWiBQbEWMNU2Bb1TNeljDBkGUJyQRziUsw924SMeJQKh2MyG8KZI6VEQjqSWsjmtkfMHFj-zT1gvmT-TrXe2N_zZ41V3qq3eLPp_nwCLQix-Q1eyn4O
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.12122/j.issn.1673-4254.2024.07.04
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Euonymus alatus delays progression of diabetic kidney disease in mice by regulating EGFR tyrosine kinase inhibitor resistance signaling pathway
EndPage 1255
ExternalDocumentID dyjydxxb202407004
GroupedDBID ---
2B.
4A8
92F
92I
93N
ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CW9
F5P
PSX
RPM
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1044-46e876c3bb6a5a271efde595b64dc830a5c66e9d45425da9fff2ef9f6728d8c53
ISSN 1673-4254
IngestDate Thu May 29 04:08:05 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 7
Keywords 糖尿病肾病
网络药理学
diabetic kidney disease
GEO database
动物实验
GEO数据库
animal experiments
euonymus alatus
molecular docking
signaling pathways
network pharmacology
信号通路
鬼箭羽
分子对接
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1044-46e876c3bb6a5a271efde595b64dc830a5c66e9d45425da9fff2ef9f6728d8c53
PageCount 13
ParticipantIDs wanfang_journals_dyjydxxb202407004
PublicationCentury 2000
PublicationDate 2024
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024
PublicationDecade 2020
PublicationTitle 南方医科大学学报
PublicationTitle_FL Journal of Southern Medical University
PublicationYear 2024
Publisher 河南中医药大学医学院,河南 郑州 450046
Publisher_xml – name: 河南中医药大学医学院,河南 郑州 450046
SSID ssib051370560
ssib006562552
ssj0002923145
ssib002263520
ssib001186833
Score 2.416671
Snippet 目的 结合GEO数据库利用网络药理学、分子对接技术及动物实验探究鬼箭羽治疗糖尿病肾病(DKD)的潜在作用机制.方法 通过TCMSP、PubChem及Swiss Target Prediction数据库获取鬼...
SourceID wanfang
SourceType Aggregation Database
StartPage 1243
Title 鬼箭羽通过调节EGFR酪氨酸激酶抑制剂耐药信号通路延缓糖尿病肾病的进展
URI https://d.wanfangdata.com.cn/periodical/dyjydxxb202407004
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAQN
  databaseName: PubMed Central
  issn: 1673-4254
  databaseCode: RPM
  dateStart: 20170101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  omitProxy: true
  ssIdentifier: ssj0002923145
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-lgnjxAxW_KdI5ldRNMpOZOSa7iUXQg7TQW0k2GcXDCraFtqdSXdSCqIgK9eRNRG1FaAVr959xu9n_wvdms9nUFqleso-X99783rydzJthPgxjFPpkFYvEMWlCKyYVLjVjlbimJRRPHSdhkcT9zjdvuRNT9MY0mx4aPlFatTQ_F4_Xlw7cV_I_UQUexBV3yf5DZAujwAAa4gtPiDA8DxVjEkjiVYlfJQEnXkC8GhJ-QPwavsJFDB4JBPFDAmN-JCpEOEgIjwg7uB7e1nKMeCDn4mtP5BxfaE6IVnKOixzQlBYJGBFCc4CAt7Y2iosmNFEjXkgCiupeTzgkPt-LiWsZMOtrOxzdkI4mHCK1ZcADFoAjOQJAyza6N-BwtCZo7qT0tZZFejdq9pNuDaCGKoAfLPtSc6pYNFYczz3yKNJIAH63RGivPdb_c6KSCIjQ2qCaI0JiIAI4KJE0L1Jo5z1wLChbgWpH-xKRYwioroRwj5VKH6-ODyo5AKc8W2MP5ml1zGyswYHPFGOJf43C5yJCB_mcyxQcAAfIbWiL-42P6ZA6ef1BSGUwRhnOhpQ6O5dDG7V7h3j3e8PeaZx5q-elrg0SQaeUJkFizA7sgiEXsnUfjGWMF2WMY23oc3LpIPUoFoQmi_cWk4WFGIUqXB_we8TGGbY_5t8svN3BKSegkDCXBjwujudZkbAzy-GV_gQA5mY2jmf0zeUFsKPGaB_2tb-A1pv6Gipq3Cnln5MnjeP5wHHE630FThlDS3dPG1H303bny-fOzs_u8lrWepxtPMxWV7Bdd5sfdzc-dJvfd1vL3ebm7urL9pPN9tOVbPlF9mz9V-t9-_kW6mytt39sdrZfdb69aW-0Om-b2coOPDtrj7LWu_bX12eMqTCYrE6Y-aUp5qxVodSkbgoJTt2JYzdikc2tVCUpkyx2aVIXTiVidddNZUIZOJhEUillp0oql9siEXXmnDWGG_cb6TljRMUyVSm34kSmNJIUfhOVKviUW1RB7Zw3ruZVMpN_FGdn9gXywmGELhrHkO5NbV4yhucezKeXIdmfi6_o-P8GE0PKRw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%AC%BC%E7%AE%AD%E7%BE%BD%E9%80%9A%E8%BF%87%E8%B0%83%E8%8A%82EGFR%E9%85%AA%E6%B0%A8%E9%85%B8%E6%BF%80%E9%85%B6%E6%8A%91%E5%88%B6%E5%89%82%E8%80%90%E8%8D%AF%E4%BF%A1%E5%8F%B7%E9%80%9A%E8%B7%AF%E5%BB%B6%E7%BC%93%E7%B3%96%E5%B0%BF%E7%97%85%E8%82%BE%E7%97%85%E7%9A%84%E8%BF%9B%E5%B1%95&rft.jtitle=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5&rft.au=%E7%8E%8B%E7%91%BE%E7%91%BE&rft.au=%E5%B4%94%E6%96%87%E9%A3%9E&rft.au=%E7%AA%A6%E9%9B%AA%E4%BC%9F&rft.au=%E5%B0%B9%E5%86%B0%E7%A3%8A&rft.date=2024&rft.pub=%E6%B2%B3%E5%8D%97%E4%B8%AD%E5%8C%BB%E8%8D%AF%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E9%99%A2%2C%E6%B2%B3%E5%8D%97+%E9%83%91%E5%B7%9E+450046&rft.issn=1673-4254&rft.volume=44&rft.issue=7&rft.spage=1243&rft.epage=1255&rft_id=info:doi/10.12122%2Fj.issn.1673-4254.2024.07.04&rft.externalDocID=dyjydxxb202407004
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fdyjydxxb%2Fdyjydxxb.jpg